James Vane
Stock Analyst at Jefferies
(1.55)
# 3,598
Out of 5,099 analysts
502
Total ratings
52.4%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by James Vane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €30.00 | €39.04 | -23.16% | 94 | Nov 3, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €55.00 | €48.81 | +12.68% | 87 | Nov 2, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Hold | €26.80 | €32.20 | -16.77% | 42 | Oct 30, 2026 | |
| ETR: SRT Sartorius Aktiengesellschaft | Reiterated: Buy | €246.00 → €253.00 | €229.00 | +10.48% | 3 | Oct 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €315.00 | €292.70 | +7.62% | 37 | Oct 29, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €266.00 | €223.40 | +19.07% | 16 | Oct 29, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 827p | 545p | +51.74% | 5 | Oct 26, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €144.00 | €149.15 | -3.45% | 8 | Oct 19, 2026 | |
| LON: CVSG CVS Group plc | Reiterated: Hold | 1,400p | 1,367p | +2.41% | 19 | Sep 25, 2026 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,025p | 1,743p | +16.18% | 29 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 93.00 → CHF 94.00 | CHF 82.78 | +13.55% | 8 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €17.30 | €24.50 | -29.39% | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €361.00 → €360.00 | €354.50 | +1.55% | 14 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 798.00 → CHF 781.00 | CHF 652.20 | +19.75% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | zł 188.00 → zł 176.00 | zł 147.50 | +19.32% | 4 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 94.50 → CHF 88.00 | CHF 72.00 | +22.22% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €83.50 → €64.20 | €63.20 | +1.58% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 110.00 | CHF 131.50 | -16.35% | 2 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.70 | - | 24 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | CHF 49.30 | CHF 80.80 | n/a | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 260p → 298p | 248p | n/a | 17 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €49.00 → €61.50 | €53.00 | n/a | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $17 → $18 | $21.73 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9.3 → $11 | $13.61 | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €4.49 | €3.20 | n/a | 7 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €49.00 | €43.35 | n/a | 23 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 147.00 → CHF 148.00 | CHF 101.05 | n/a | 4 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 300p | 244p | n/a | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €135.00 → €43.00 | €9.91 | n/a | 2 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.66 | n/a | 1 | Dec 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 93.00 | kr 276.00 | n/a | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $31 | $14.30 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $47.09 | n/a | 1 | Aug 21, 2017 |
Fresenius Medical Care AG
Nov 3, 2026
Reiterated: Sell
Price Target: €30.00
Current: €39.04
Upside: -23.16%
Fresenius SE & Co. KGaA
Nov 2, 2026
Reiterated: Buy
Price Target: €55.00
Current: €48.81
Upside: +12.68%
Gerresheimer AG
Oct 30, 2026
Reiterated: Hold
Price Target: €26.80
Current: €32.20
Upside: -16.77%
Sartorius Aktiengesellschaft
Oct 29, 2026
Reiterated: Buy
Price Target: €246.00 → €253.00
Current: €229.00
Upside: +10.48%
Sartorius Aktiengesellschaft
Oct 29, 2026
Reiterated: Buy
Price Target: €315.00
Current: €292.70
Upside: +7.62%
Sartorius Stedim Biotech S.A.
Oct 29, 2026
Reiterated: Buy
Price Target: €266.00
Current: €223.40
Upside: +19.07%
Oxford Biomedica plc
Oct 26, 2026
Reiterated: Buy
Price Target: 827p
Current: 545p
Upside: +51.74%
Merck KGaA
Oct 19, 2026
Reiterated: Hold
Price Target: €144.00
Current: €149.15
Upside: -3.45%
CVS Group plc
Sep 25, 2026
Reiterated: Hold
Price Target: 1,400p
Current: 1,367p
Upside: +2.41%
Hikma Pharmaceuticals PLC
Sep 25, 2026
Reiterated: Buy
Price Target: 2,025p
Current: 1,743p
Upside: +16.18%
Sep 10, 2026
Reiterated: Buy
Price Target: CHF 93.00 → CHF 94.00
Current: CHF 82.78
Upside: +13.55%
Aug 12, 2026
Reiterated: Hold
Price Target: €17.30
Current: €24.50
Upside: -29.39%
Jul 31, 2026
Reiterated: Hold
Price Target: €361.00 → €360.00
Current: €354.50
Upside: +1.55%
Jul 28, 2026
Reiterated: Buy
Price Target: CHF 798.00 → CHF 781.00
Current: CHF 652.20
Upside: +19.75%
Jul 13, 2026
Reiterated: Hold
Price Target: zł 188.00 → zł 176.00
Current: zł 147.50
Upside: +19.32%
May 13, 2026
Reiterated: Hold
Price Target: CHF 94.50 → CHF 88.00
Current: CHF 72.00
Upside: +22.22%
May 13, 2026
Reiterated: Hold
Price Target: €83.50 → €64.20
Current: €63.20
Upside: +1.58%
Apr 28, 2026
Reiterated: Hold
Price Target: CHF 110.00
Current: CHF 131.50
Upside: -16.35%
Jan 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $25.70
Upside: -
Sep 25, 2025
Initiated Coverage: Sell
Price Target: CHF 49.30
Current: CHF 80.80
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: 260p → 298p
Current: 248p
Upside: n/a
Aug 11, 2025
Upgraded: Buy
Price Target: €49.00 → €61.50
Current: €53.00
Upside: n/a
Aug 8, 2024
Reiterated: Sell
Price Target: $17 → $18
Current: $21.73
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $9.3 → $11
Current: $13.61
Upside: n/a
Jan 5, 2024
Reiterated: Hold
Price Target: €4.49
Current: €3.20
Upside: n/a
Nov 8, 2023
Reiterated: Hold
Price Target: €49.00
Current: €43.35
Upside: n/a
Feb 23, 2023
Reiterated: Buy
Price Target: CHF 147.00 → CHF 148.00
Current: CHF 101.05
Upside: n/a
Nov 22, 2022
Initiated Coverage: Buy
Price Target: 300p
Current: 244p
Upside: n/a
Jan 28, 2022
Downgraded: Hold
Price Target: €135.00 → €43.00
Current: €9.91
Upside: n/a
Dec 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $9.66
Upside: n/a
Nov 1, 2018
Reiterated: Buy
Price Target: kr 93.00
Current: kr 276.00
Upside: n/a
Nov 1, 2017
Reiterated: Sell
Price Target: $31
Current: $14.30
Upside: n/a
Aug 21, 2017
Upgraded: Hold
Price Target: n/a
Current: $47.09
Upside: n/a